Skip to main navigation Skip to search Skip to main content

Working Hard or Hardly Working? Regulatory Bottlenecks in Developing a COVID-19 Vaccine

  • Lisette Pregelj
  • , Damian Hine
  • , Maria Oyola-Lozada
  • , Trent Munro

Research output: Contribution to journal › Article › Research › peer-review

Abstract

Vaccine solutions rarely reach the public until after an outbreak abates; an Ebola vaccine was approved 5 years after peak outbreak and SARS, MERS, and Zika vaccines are still in clinical development. Despite massive leaps forward in rapid science, other regulatory bottlenecks are hamstringing the global effort for pandemic vaccines.
Original languageEnglish
Pages (from-to)943-947
Number of pages5
JournalTrends in Biotechnology
Volume38
Issue number9
DOIs
Publication statusPublished - Sept 2020
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Working Hard or Hardly Working? Regulatory Bottlenecks in Developing a COVID-19 Vaccine'. Together they form a unique fingerprint.

Cite this